Cargando…
Microglial SIRT1 activation attenuates synapse loss in retinal inner plexiform layer via mTORC1 inhibition
BACKGROUND: Optic nerve injury (ONI) is a key cause of irreversible blindness and triggers retinal ganglion cells (RGCs) change and synapse loss. Microglia is the resistant immune cell in brain and retina and has been demonstrated to be highly related with neuron and synapse injury. However, the fun...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481494/ https://www.ncbi.nlm.nih.gov/pubmed/37670386 http://dx.doi.org/10.1186/s12974-023-02886-8 |
_version_ | 1785101986892349440 |
---|---|
author | Yao, Ke Mou, Qianxue Lou, Xiaotong Ye, Meng Zhao, Bowen Hu, Yuanyuan Luo, Jing Zhang, Hong Li, Xing Zhao, Yin |
author_facet | Yao, Ke Mou, Qianxue Lou, Xiaotong Ye, Meng Zhao, Bowen Hu, Yuanyuan Luo, Jing Zhang, Hong Li, Xing Zhao, Yin |
author_sort | Yao, Ke |
collection | PubMed |
description | BACKGROUND: Optic nerve injury (ONI) is a key cause of irreversible blindness and triggers retinal ganglion cells (RGCs) change and synapse loss. Microglia is the resistant immune cell in brain and retina and has been demonstrated to be highly related with neuron and synapse injury. However, the function of Sirtuin 1 (SIRT1), a neuroprotective molecule, in mediating microglial activation, retinal synapse loss and subsequent retinal ganglion cells death in optic nerve injury model as well as the regulatory mechanism remain unclear. METHOD: To this end, optic nerve crush (ONC) model was conducted to mimic optic nerve injury. Resveratrol and EX527, highly specific activator and inhibitor of SIRT1, respectively, were used to explore the function of SIRT1 in vivo and vitro. Cx3Cr1-Cre(ERT2)/Raptor(F/F) mice were used to delete Raptor for inhibiting mammalian target of rapamycin complex 1 (mTORC1) activity in microglia. HEK293 and BV2 cells were transfected with plasmids to explore the regulatory mechanism of SIRT1. RESULTS: We discovered that microglial activation and synapse loss in retinal inner plexiform layer (IPL) occurred after optic nerve crush, with later-development retinal ganglion cells death. SIRT1 activation induced by resveratrol inhibited microglial activation and attenuated synapse loss and retinal ganglion cells injury. After injury, microglial phagocytosed synapse and SIRT1 inhibited this process to protect synapse and retinal ganglion cells. Moreover, SIRT1 exhibited neuron protective effects via activating tuberous sclerosis complex 2 (TSC2) through deacetylation, and enhancing the inhibition effect of tuberous sclerosis complex 2 on mammalian target of rapamycin complex 1 activity. CONCLUSION: Our research provides novel insights into microglial SIRT1 in optic nerve injury and suggests a potential strategy for neuroprotective treatment of optic nerve injury disease. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12974-023-02886-8. |
format | Online Article Text |
id | pubmed-10481494 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-104814942023-09-07 Microglial SIRT1 activation attenuates synapse loss in retinal inner plexiform layer via mTORC1 inhibition Yao, Ke Mou, Qianxue Lou, Xiaotong Ye, Meng Zhao, Bowen Hu, Yuanyuan Luo, Jing Zhang, Hong Li, Xing Zhao, Yin J Neuroinflammation Research BACKGROUND: Optic nerve injury (ONI) is a key cause of irreversible blindness and triggers retinal ganglion cells (RGCs) change and synapse loss. Microglia is the resistant immune cell in brain and retina and has been demonstrated to be highly related with neuron and synapse injury. However, the function of Sirtuin 1 (SIRT1), a neuroprotective molecule, in mediating microglial activation, retinal synapse loss and subsequent retinal ganglion cells death in optic nerve injury model as well as the regulatory mechanism remain unclear. METHOD: To this end, optic nerve crush (ONC) model was conducted to mimic optic nerve injury. Resveratrol and EX527, highly specific activator and inhibitor of SIRT1, respectively, were used to explore the function of SIRT1 in vivo and vitro. Cx3Cr1-Cre(ERT2)/Raptor(F/F) mice were used to delete Raptor for inhibiting mammalian target of rapamycin complex 1 (mTORC1) activity in microglia. HEK293 and BV2 cells were transfected with plasmids to explore the regulatory mechanism of SIRT1. RESULTS: We discovered that microglial activation and synapse loss in retinal inner plexiform layer (IPL) occurred after optic nerve crush, with later-development retinal ganglion cells death. SIRT1 activation induced by resveratrol inhibited microglial activation and attenuated synapse loss and retinal ganglion cells injury. After injury, microglial phagocytosed synapse and SIRT1 inhibited this process to protect synapse and retinal ganglion cells. Moreover, SIRT1 exhibited neuron protective effects via activating tuberous sclerosis complex 2 (TSC2) through deacetylation, and enhancing the inhibition effect of tuberous sclerosis complex 2 on mammalian target of rapamycin complex 1 activity. CONCLUSION: Our research provides novel insights into microglial SIRT1 in optic nerve injury and suggests a potential strategy for neuroprotective treatment of optic nerve injury disease. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12974-023-02886-8. BioMed Central 2023-09-05 /pmc/articles/PMC10481494/ /pubmed/37670386 http://dx.doi.org/10.1186/s12974-023-02886-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Yao, Ke Mou, Qianxue Lou, Xiaotong Ye, Meng Zhao, Bowen Hu, Yuanyuan Luo, Jing Zhang, Hong Li, Xing Zhao, Yin Microglial SIRT1 activation attenuates synapse loss in retinal inner plexiform layer via mTORC1 inhibition |
title | Microglial SIRT1 activation attenuates synapse loss in retinal inner plexiform layer via mTORC1 inhibition |
title_full | Microglial SIRT1 activation attenuates synapse loss in retinal inner plexiform layer via mTORC1 inhibition |
title_fullStr | Microglial SIRT1 activation attenuates synapse loss in retinal inner plexiform layer via mTORC1 inhibition |
title_full_unstemmed | Microglial SIRT1 activation attenuates synapse loss in retinal inner plexiform layer via mTORC1 inhibition |
title_short | Microglial SIRT1 activation attenuates synapse loss in retinal inner plexiform layer via mTORC1 inhibition |
title_sort | microglial sirt1 activation attenuates synapse loss in retinal inner plexiform layer via mtorc1 inhibition |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481494/ https://www.ncbi.nlm.nih.gov/pubmed/37670386 http://dx.doi.org/10.1186/s12974-023-02886-8 |
work_keys_str_mv | AT yaoke microglialsirt1activationattenuatessynapselossinretinalinnerplexiformlayerviamtorc1inhibition AT mouqianxue microglialsirt1activationattenuatessynapselossinretinalinnerplexiformlayerviamtorc1inhibition AT louxiaotong microglialsirt1activationattenuatessynapselossinretinalinnerplexiformlayerviamtorc1inhibition AT yemeng microglialsirt1activationattenuatessynapselossinretinalinnerplexiformlayerviamtorc1inhibition AT zhaobowen microglialsirt1activationattenuatessynapselossinretinalinnerplexiformlayerviamtorc1inhibition AT huyuanyuan microglialsirt1activationattenuatessynapselossinretinalinnerplexiformlayerviamtorc1inhibition AT luojing microglialsirt1activationattenuatessynapselossinretinalinnerplexiformlayerviamtorc1inhibition AT zhanghong microglialsirt1activationattenuatessynapselossinretinalinnerplexiformlayerviamtorc1inhibition AT lixing microglialsirt1activationattenuatessynapselossinretinalinnerplexiformlayerviamtorc1inhibition AT zhaoyin microglialsirt1activationattenuatessynapselossinretinalinnerplexiformlayerviamtorc1inhibition |